Ibrexafungerp Citrate is a triterpenoid antifungal API used to treat fungal infections, particularly vulvovaginal candidiasis. It works by inhibiting fungal glucan synthase, disrupting the fungal cell wall. It is a small-molecule chemical API, not a peptide or oligonucleotide. Its therapeutic use is listed as antifungals. Other names for this substance include brexafemme and SCY-078 citrate. Its PubChem CID is 137552087.
Ibrexafungerp Citrate
| CAS No | 1965291-08-0 |
|---|---|
| Molecular Formula | C50H75N5O11 |
| Molecular Weight | 922.2 g/mol |
| Synonyms | (1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-[(2R)-2-amino-2,3,3-trimethylbutoxy]-5,7,10,15-tetramethyl-7-[(2R)-3-methylbutan-2-yl]-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2-ene-6-carboxylic acid;2-hydroxypropane-1,2,3-tricarboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ibrexafungerp Citrate is a triterpenoid antifungal API used to treat fungal infections, particularly vulvovaginal candidiasis. It works by inhibiting fungal glucan synthase, disrupting the fungal cell wall.
The listed CAS number is 1965291-08-0.
The listed molecular formula is C50H75N5O11.
The listed molecular weight is 922.2 g/mol.
(1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-[(2R)-2-amino-2,3,3-trimethylbutoxy]-5,7,10,15-tetramethyl-7-[(2R)-3-methylbutan-2-yl]-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2-ene-6-carboxylic acid;2-hydroxypropane-1,2,3-tricarboxylic acid.
The source lists brexafemme and SCY-078 citrate.